Tagged Articles

Valeant Pharmaceuticals International 2 articles

Investors of ‘female Viagra’ pill sue manufacturer over botched marketing

It was a red-letter day in October 2015 when the Food and Drug Administration (FDA) approved the first female sexual enhancement medication for marketing in the U.S. The so-called female Viagra, sold under the brand name Addyi, had been rejected twice in the five years prior over doubts about its effectiveness and concerns of potential side effects. When it finally hit the market, expectations were high. A year later, Valeant Pharmaceuticals International Inc., which acquired the female libido pill from Sprout Pharmaceuticals Inc. in a $1 billion buyout last year, was slapped with a lawsuit by former Sprout investors. The lawsuit ... Read More

Valeant, Sprout announce partnership days after approval of so-called female Viagra

Two days after Sprout Pharmaceuticals Inc. made history by becoming the first drug company to gain approval for a so-called female Viagra pill, Valeant Pharmaceuticals International Inc. announced that it would be shelling out $1 billion in cash to buy Sprout. Sprout’s drug flibanserin, which will be sold under the brand name Addyi, is designed to treat low sexual desire in premenopausal women. The drug was approved amid controversy that included skepticism from researchers that the drug actually worked, and women’s advocacy groups that argued drug regulators were more reluctant to approve a sexual enhancement drug for women despite there being several ... Read More